Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome
Sophie Hüe, Asma Beldi‐Ferchiou, Inès Bendib, et al.
American Journal of Respiratory and Critical Care Medicine (2020) Vol. 202, Iss. 11, pp. 1509-1519
Open Access | Times Cited: 187

Showing 1-25 of 187 citing articles:

Global absence and targeting of protective immune states in severe COVID-19
Alexis J. Combes, Tristan Courau, Nicholas F. Kuhn, et al.
Nature (2021) Vol. 591, Iss. 7848, pp. 124-130
Open Access | Times Cited: 247
Chemokines and chemokine receptors during COVID-19 infection
Bariaa Khalil, Noha Mousaad Elemam, Azzam A. Maghazachi
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 976-988
Open Access | Times Cited: 209
The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved
Francesca Coperchini, Luca Chiovato, Gianluca Ricci, et al.
Cytokine & Growth Factor Reviews (2021) Vol. 58, pp. 82-91
Open Access | Times Cited: 123
Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis
Rundong Qin, Li He, Zhaowei Yang, et al.
Clinical Reviews in Allergy & Immunology (2022) Vol. 64, Iss. 1, pp. 33-65
Open Access | Times Cited: 72
Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES): an international, multicentre, retrospective cohort study
Matthieu Schmidt, David Hajage, Micha Landoll, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 2, pp. 163-175
Open Access | Times Cited: 39
Comparative Study of Cytokine Profiles in SARS-CoV-2 Delta and Omicron Variants
Michaela Krivosova, Juliana Hanusrichterová, Vincent Lučanský, et al.
Bratislavské lekárske listy/Bratislava medical journal (2025)
Open Access | Times Cited: 1
The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients
Matthieu Perreau, Madeleine Suffiotti, Pedro Marques–Vidal, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 98
Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions
Robert Root‐Bernstein
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2108-2108
Open Access | Times Cited: 95
The cytokine storm and thyroid hormone changes in COVID-19
Laura Croce, Dave Gangemi, Giuseppe Ancona, et al.
Journal of Endocrinological Investigation (2021) Vol. 44, Iss. 5, pp. 891-904
Open Access | Times Cited: 89
SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives
Rosaria Maddalena Ruggeri, Alfredo Campennì, Désirèe Deandreis, et al.
Expert Review of Clinical Immunology (2021) Vol. 17, Iss. 7, pp. 737-759
Open Access | Times Cited: 75
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients
Marco Contoli, Alberto Papi, Luca Tomassetti, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 72
The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome
Mathieu Blot, Jean‐Baptiste Bour, Jean‐Pierre Quenot, et al.
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 70
Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19
Lowell Ling, Zigui Chen, Grace Lui, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 68
Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial
Paul Cremer, Antonio Abbate, Kristin Hudock, et al.
The Lancet Rheumatology (2021) Vol. 3, Iss. 6, pp. e410-e418
Open Access | Times Cited: 65
CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study
Nicola Ivan Lorè, Rebecca De Lorenzo, Paola M. V. Rancoita, et al.
Molecular Medicine (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 65
Observational cohort study of IP-10’s potential as a biomarker to aid in inflammation regulation within a clinical decision support protocol for patients with severe COVID-19
Shaul Lev, Tamar Gottesman, Gal Sahaf Levin, et al.
PLoS ONE (2021) Vol. 16, Iss. 1, pp. e0245296-e0245296
Open Access | Times Cited: 58
SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases
Avaniyapuram Kannan Murugan, Ali S. Alzahrani
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 6191-6221
Open Access | Times Cited: 55
Attributable Mortality of Ventilator-associated Pneumonia Among Patients with COVID-19
Charles‐Hervé Vacheron, Alain Lepape, Anne Savey, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 206, Iss. 2, pp. 161-169
Open Access | Times Cited: 52
CXCL10 Chemokine: A Critical Player in RNA and DNA Viral Infections
Noha Mousaad Elemam, Iman M. Talaat, Azzam A. Maghazachi
Viruses (2022) Vol. 14, Iss. 11, pp. 2445-2445
Open Access | Times Cited: 46
Increased Circulating Cytokines Have a Role in COVID-19 Severity and Death With a More Pronounced Effect in Males: A Systematic Review and Meta-Analysis
Huating Hu, Hudan Pan, Runze Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 44
Associations between Serum Interleukins (IL-1β, IL-2, IL-4, IL-6, IL-8, and IL-10) and Disease Severity of COVID-19: A Systematic Review and Meta-Analysis
Yuanmin Chang, Mengru Bai, Qinghai You
BioMed Research International (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 42
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)
Jatin Patel, Damon Bass, Albertus Beishuizen, et al.
European Respiratory Journal (2022) Vol. 61, Iss. 2, pp. 2101870-2101870
Open Access | Times Cited: 39
ASGARD is A Single-cell Guided Pipeline to Aid Repurposing of Drugs
Bing He, Yao Xiao, Haodong Liang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 26
Persistent alveolar inflammatory response in critically ill patients with COVID-19 is associated with mortality
Justin de Brabander, Leonoor S. Boers, Robert F. J. Kullberg, et al.
Thorax (2023) Vol. 78, Iss. 9, pp. 912-921
Open Access | Times Cited: 25
Acute respiratory distress syndrome
Katherine D. Wick, Lorraine B. Ware, Michael A. Matthay
BMJ (2024), pp. e076612-e076612
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top